Ikarian Capital’s Curis CRIS Stock Holding History

Ikarian Capital’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-250	Closed	-$1.13M	–	235
2021 Q1	$1.13M	Sell	250 -1,031	-80%	-$4.31M	0.04%	234
2020 Q4	$4.2M	Buy	+1,281	New	+$1.54M	0.19%	106

Other funds holding CRIS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Ikarian Capital's CRIS Position: Q2 2021 in Review

Ikarian Capital sold out of Curis (CRIS) in Q2 2021, closing a stake of 3,051 shares — an estimated $13.8M sold.

Ikarian Capital first reported a position in CRIS in Q4 2020 and held it in 2 quarters. The position peaked at $13.8M in Q1 2021. 127 funds tracked by Wall St. Rank hold CRIS as of Q2 2021.

Ikarian Capital reported no remaining Curis position as of Q2 2021 after selling out during the quarter.
Ikarian Capital sold 3,051 Curis shares in Q2 2021, an estimated $13.8M.
Ikarian Capital first reported a position in Curis in Q4 2020 and held it in 2 quarters.
Ikarian Capital's Curis position peaked at $13.8M in Q1 2021.
127 funds tracked by Wall St. Rank held Curis as of Q2 2021.

Based on Ikarian Capital's 13F filing for Q2 2021, filed 16 Aug 2021.